Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
18 Leser
Artikel bewerten:
(0)

Caldwell Partners Strengthens Life Sciences & Healthcare Practice in London

TORONTO, July 2, 2015 /PRNewswire/ --

Christopher Coe brings 30 years of executive search and life sciences industry experience

Retained executive search firm The Caldwell Partners International Inc. (TSX: CWL) today announced that Christopher Coe has joined the firm as a Senior Partner in the Life Sciences & Healthcare practice, focusing on recruiting senior executives for clients in the medical devices, diagnostics, and tools industry in Europe.

"We are delighted to be expanding our capabilities in life sciences and healthcare into the European market with a search consultant of Chris' calibre," said Darin A. DeWitt, leader of the firm's Life Sciences & Healthcare Practice. "With nearly 15 years of experience in the life sciences industry, Chris is able to leverage his knowledge of the pharmaceutical, biotech, medical devices, diagnostics, and tools space to his clients' advantage. His insight and grounded expertise make him a wonderful complement to the North American team, and our clients will be the immediate beneficiaries of our strengthened ability to execute searches on a global scale."

Mr. Coe joins Caldwell Partners from CTPartners, where he was the co-practice lead and led the firm's Life Sciences Practice in Europe. He was previously a senior client partner in Korn/Ferry International's Healthcare Practice. Prior to joining the executive search industry, Mr. Coe had a successful corporate career as a respected marketing & sales executive with major global pharmaceutical and medical devices companies, including GD Searle, Medtronic, Boston Scientific and VC backed start-up organisations.

"Our strategy for Caldwell Partners Europe is to replicate the success that has become more and more evident in Caldwell Partners in North America," said Matthew Andrews, managing director of Caldwell Partners, Europe. "We are looking to attract passionate, credible, high-end search consultants who know their markets very well, who are respected by their clients and who can help us build a premium, very sector specific search and advisory business. Christopher Coe is a perfect example of this profile."

Mr. Coe graduated from City of London University with a BSC Hons in ecology & geomorphology.

About Caldwell Partners

Caldwell Partners is a leading international provider of executive search and has been for more than 40 years. As one of the world's most trusted advisors in executive search, the firm has a sterling reputation built on successful searches for boards, chief and senior executives, and selected functional experts. With offices and partners across North America and in London, the firm takes pride in delivering an unmatched level of service and expertise to its clients.

The Caldwell Partners' Common shares are listed on The Toronto Stock Exchange (TSX: CWL). Please visit our website athttp://www.caldwellpartners.comfor further information.

Caroline Lomot, Caldwell Partners, clomot@caldwellpartners.com , +1-516-830-3535


Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.